Bladder Cancer - Results from #200

Efficacy and Safety of Neoadjuvant Immunotherapy in Combination with Neoadjuvant Gemcitabine and Cisplatin - Expert Commentary December 15, 2022

Switch-maintenance avelumab immunotherapy following first-line chemotherapy for patients with advanced, unresectable or metastatic urothelial carcinoma: the first Japanese real-world evidence from a multicenter study. December 15, 2022

Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis. December 15, 2022

Radical cystectomy and urinary diversion in women: techniques, outcomes, and challenges-a narrative review. December 14, 2022

Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study. December 14, 2022

Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors. December 14, 2022

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype. December 13, 2022

Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial Group. December 13, 2022

Oncologic outcomes of neoadjuvant chemotherapy in patients with micropapillary variant urothelial carcinoma of the bladder. December 12, 2022

Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma. December 12, 2022

The cytidine deaminase APOBEC3G contributes to cancer mutagenesis and clonal evolution in bladder cancer. December 12, 2022

Complications after neoadjuvant chemotherapy and radical cystectomy for patients with bladder cancer: A propensity score matched analysis. December 9, 2022

Urine-Based Markers for Detection of Urothelial Cancer and for the Management of Non-muscle-Invasive Bladder Cancer. December 9, 2022

A Deep Learning Model for Guiding Precision Therapy in Bladder Cancer - Expert Commentary December 8, 2022

The effect of chemotherapy in sarcomatoid bladder cancer patients treated with radical cystectomy. December 8, 2022

Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer: A pairwise meta-analysis of outcomes and a network meta- analysis of complications by urinary diversion approach. December 8, 2022

Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer. December 8, 2022

Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resection. December 7, 2022

Global changes in bladder cancer mortality in the elderly. December 7, 2022

A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy. December 7, 2022

Page 11 of 458